| HOME >> BIOLOGY >> TECHNOLOGY |
Statements made in this press release relating to plans, strategies,
objectives, economic performance and trends and other statements that are
not descriptions of historical facts may be forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended
(the "Securities Act"), and Section 21E of the Securities Exchange Act of
1934, as amended (the "Exchange Act"). Forward-looking information is
inherently subject to risks and uncertainties, and actual results could
differ materially from those currently anticipated due to a number of
factors, which include, but are not limited to, the factors set forth under
the heading "Risk Factors" in our annual report on Form 10-K for the year
ended March 31, 2007, updates and additions to those "Risk Factors" in our
interim reports on Form 10-Q, Forms 8-K and in other documents filed by us
with the Securities and Exchange Commission from time to time. In
particular, forward-looking statements made in this press release are
subject to risks and uncertainties such that there can be no assurances
whatsoever: that the shelf registration statement will be declared
effective or that if so will not require further filings with or
accelerations by the SEC; that the healthcare business in China will
continue to grow at recent or other anticipated rates; that any strategic
opportunities will become available to the Company or, if pursued, will
prove to be successful; that the shelf registration statement will provide
actual benefits to the Company in achieving any such opportunities or such
success; that any offering under the shelf registration statement will be
consummated without dilution to stockholders; that the revenues or
operating income as a percentage of revenues of the hospital division will
increase in the
'/>"/>
| SOURCE Chindex International, Inc. Copyright©2008 PR Newswire. All rights reserved |